Leaving MS Behind
He’s a keen runner, practises one of the oldest surviving Japanese martial arts—Katori Shinto Ryu—and is driven by his curiosity
Music to our patient’s ears
It is well known that significant numbers of post-transplant patients have reduced quality of life, such as tiredness from anxiety/stress,
Haematopoietic Stem Cell Transplant Research Funding
With the uncertain economic outlook due to COVID, never has it been more important for charities like Arrow to keep
Arrow / HCC PhD scholarship awarded to Natalia Pinello
We are pleased to award Arrow / HCC scholarship funding to Natalia Pinello from The Centenary Institute, providing approximately $13,000
Arrow and the Hawkesbury Canoe Classic (HCC) fund targeted therapies
The vital work of Arrow / HCC research scientist, Dr Tim Molloy, and projects undertaken by Arrow / HCC PhD
Record donation of $1 million to Arrow for Stem Cell Transplantation research
Arrow is pleased to announce that Vicki and Michael Quigley have donated $1 million to Arrow to support the research
Latest Arrow/HCC achievements in research
Arrow/HCC Research Scientist 2017 report In 2017 Dr Melinda Tursky continued her research in targeting genes which drive the progression
Where are they now?
It’s always interesting to hear what our past Arrow/HCC PhD Scholarships recipients are up to and we recently received an
Clinical trial gives new hope to patients without matched donors
In 2016, Arrow provided a grant of $100,000 to a clinical trial offering hope to transplant patients without a matched
Arrow grant helps in developing new therapies and diagnostic tests
Written by Dr. Tim Molloy (senior researcher) The Blood, Stem Cell, and Cancer Research (BSSCR) laboratory is a multidisciplinary research
ABMTRR releases 25 years of Registry data
This year the Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) marks 25 years and has included an extra section in
Arrow funds a literature review
Nurses and dietitians caring for people post-transplant have noted in their clinical work that despite the current management, patients who